Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02274857 · ClinicalTrials.gov registry record · NA
Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures
A NA study of Persistent Atrial Fibrillation, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 18
- Study locations
NCT02274857: Completed NA study of Persistent Atrial Fibrillation, sponsored by Abbott Medical Devices.
NCT02274857 is a NA study of Persistent Atrial Fibrillation that has completed, run by Abbott Medical Devices. The registered enrollment target is 350 participants, below the 1,237-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (72% lower). The trial reports 18 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02274857, a NA study of Persistent Atrial Fibrillation, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 18
- Study locations
Study Summary
The study is a prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM procedures followed by conventional ablation including PVI versus a standard PVI procedure for the treatment of persistent atrial fibrillation (AF).
Conditions Studied
Interventions
- PROCEDURE Standard PVI Ablation
- PROCEDURE FIRM-Guided Procedure and PVI
Study Locations (18)
Other
- Unfallkrankenhaus Berlin - Berlin
- Klinikum Coburg GmbH - Coburg
- Zentrum für klinische Prüfungen in der Facharztzentrum Dresden-Neustadt GbR - Dresden
- Städtisches Klinikum Karlsruhe gGmbH - Karlsruhe
- Leipzig Heart Institute GmbH - Leipzig
- Kardiologische Gemeinschaftspraxis am Park Sanssouci - Potsdam
- Erasmus Medical Center - Rotterdam
Indiana
- Indiana University - Krannert Institute of Cardiology - Indianapolis
- St. Vincent Hospital - Indianapolis
Arizona
- Arizona Heart Rhythm Center - Phoenix
California
- Hoag Memorial Hospital Presbyterian - Newport Beach
Illinois
- Loyola University Medical Center - Maywood
Maryland
- The Johns Hopkins Hospital - Baltimore
New Jersey
- Hackensack UMC - Hackensack
New York
- Weill Medical College at Cornell University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-11-10 |
| Phase | NA |
What the finished NCT02274857 record still lists
NCT02274857 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,237-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Standard PVI Ablation is the first listed.
NCT02274857 lists 18 locations in 11 states (Other, Indiana, Arizona).
Frequently Asked Questions
What is clinical trial NCT02274857 about?
NCT02274857 is a clinical study titled "Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures". The study is a prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM procedures followed by conventional ablation including PVI versus a standard PVI procedure for the treatment of persistent atrial fibrillation (AF).
What is the current status of trial NCT02274857?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2014-10. Estimated completion is 2018-11-10.
What conditions does trial NCT02274857 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT02274857?
The interventions under investigation include: Standard PVI Ablation (PROCEDURE), FIRM-Guided Procedure and PVI (PROCEDURE).
Who is sponsoring clinical trial NCT02274857?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02274857 being conducted?
This trial has 18 study locations across Arizona, California, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02274857's enrollment target sits among peer trials
350 6th of 15 higher than 10 of 15 other Persistent Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Persistent Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia